
    
      Prospective, single center, randomized, double-masked, placebo controlled study. Subjects
      will be randomized to one of the following treatment arms to dose four times per day (QID)
      for 4 days between Visits 3 and 4.

      Prednisolone phosphate Tears Naturale II Ophthalmic Solution (Placebo)

      Duration:

      Approximately 2 weeks

      Controls:

      Artificial Tears (Tears NaturaleÂ® II)
    
  